Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1425 of 1561 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/05/18
End: 09/11/18
Due: 09/11/19
Phase: N/A
Priority: Normal
Start: 01/01/18
End: 01/06/19
Due: 01/06/20
Phase: N/A
Priority: Normal
Start: 02/01/23
End: 03/30/24
Due: 03/30/25
Phase: N/A
Priority: Normal
Start: 10/10/22
End: 05/10/23
Due: 05/10/24
Phase: N/A
Priority: Normal
Start: 01/04/24
End: 01/25/25
Due: 01/25/26
Phase: N/A
Priority: Normal
Start: 04/30/24
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 04/30/16
Due: 04/30/17
Role of Carnosine as an Adjuvant Therapy for Diabetic Nephropathy in Pediatrics With Type 1 Diabetes
Phase: N/A
Priority: Normal
Start: 08/31/15
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/13/19
End: 05/03/20
Due: 05/03/21
Phase: N/A
Priority: Normal
Start: 09/06/23
End: 09/06/24
Due: 09/06/25
Phase: N/A
Priority: Normal
Start: 05/01/19
End: 11/30/19
Due: 11/30/20
Phase: N/A
Priority: Normal
Start: 11/01/17
End: 03/01/18
Due: 03/01/19
Phase: N/A
Priority: Normal
Start: 12/04/23
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 06/30/14
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/21/19
End: 03/10/21
Due: 03/10/22
Phase: N/A
Priority: Normal
Start: 07/02/21
End: 10/30/22
Due: 10/30/23
Phase: N/A
Priority: Normal
Start: 05/30/25
End: 06/15/26
Due: 06/15/27
Phase: N/A
Priority: Normal
Start: 09/25/22
End: 10/01/23
Due: 10/01/24
Phase: N/A
Priority: Normal
Start: 06/15/22
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 07/02/18
End: 12/02/20
Due: 12/02/21
Phase: N/A
Priority: Normal
Start: 04/01/24
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 01/02/18
End: 12/10/18
Due: 12/10/19
Phase: N/A
Priority: Normal
Start: 11/30/14
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: 11/01/21
End: 10/25/22
Due: 10/25/23
Effect of Genetic Polymorphism on the Clinical Outcome to SGLT2 Inhibitors in Heart Failure Patients
Phase: N/A
Priority: Normal
Start: 11/22/23
End: 07/01/25
Due: 07/01/26